Research GradeImmune & Systemic Support

KPV

10 mg

C-terminal α-MSH tripeptide studied for anti-inflammatory pathways.

Overview

KPV (Lys-Pro-Val) is the C-terminal tripeptide of α-melanocyte-stimulating hormone, studied for its anti-inflammatory profile.

Mechanism of Action

Inhibits NF-κB signaling, reduces pro-inflammatory cytokine release (TNF-α, IL-6), and modulates mast cell activation independent of melanocortin receptor engagement.

Research Findings

KPV and Mucosal Inflammation

Gut, 2008

Colitis model attenuation.

Potential Research Applications

Anti-inflammatory research
Mucosal immunity

Often researched with

BPC-157

10 mg

Pentadecapeptide derived from gastric protein studied for systemic repair pathways.

Klow Blend

TB-500 + BPC-157 + GHK-Cu + KPV

Quad blend adding KPV anti-inflammatory tripeptide.

Thymosin Alpha-1

5 mg

Immunomodulatory thymic peptide for T-cell research.